A community program to help young women in Kenya use HIV prevention medication.

Tu'Washindi: A relationship-focused intervention to reduce GBV and increase PrEP uptake and adherence among Kenyan AGYW

NIH-funded research Research Triangle Institute · NIH-10891601

This study is testing a friendly program in Kenya to help young women and girls use and stick with a medicine called PrEP that helps prevent HIV, by providing support groups and education for both them and their partners.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Triangle Institute NIH-funded
Lab location1 site (Research Triangle Park, United States)
Project IDNIH-10891601 on NIH RePORTER

What this research studies

This research focuses on a community-based intervention aimed at increasing the use and adherence to pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) in Kenya. The program addresses the unique challenges faced by these young women, including gender inequality and the risk of intimate partner violence, which can hinder their ability to access and continue using PrEP. The intervention includes empowerment support groups, community education for male partners, and couple-focused PrEP education events, all designed to create a supportive environment for AGYW. The program is implemented over six months and aims to integrate seamlessly into existing youth programs to enhance sustainability.

Who could benefit from this research

Good fit: Ideal candidates for this research are adolescent girls and young women in Kenya, particularly those facing gender-based violence and other barriers to HIV prevention.

Not a fit: Patients who are not adolescent girls or young women, or those not living in the targeted regions of Kenya, may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of HIV infection among young women in Kenya by improving their access to and adherence to PrEP.

How similar studies have performed: Previous research has shown success with community-based interventions aimed at increasing PrEP uptake among vulnerable populations, indicating a promising approach.

Where this research is happening

Research Triangle Park, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.